Reduced Cardiac Fibrosis and Improved Ventricular Function in an Experimental Model of Myocardial Infarction Using a Purpose Designed Direct Antifibrotic Drug
To access this article, please choose from the options below
PII: S1443-9506(07)00280-6
doi:10.1016/j.hlc.2007.06.011
© 2007 Published by Elsevier Inc.
